Conference abstractPublished 6 Aug 2018
The role of mannose-binding lectin (MBL) in patients with haematological malignancies, receiving high-dose chemotherapy and autologous haematopoietic stem cell transplantations (auto-HSCT)
Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland; Copernicus Memorial Hospital in Lodz Comprehensive Cancer Center and Traumatology, Poland; Cancer Center and Institute of Oncology, Gliwice Branch, Poland; Medical University of Lodz, Poland; Department of Hematology, Institute of Hematology and Transfusion Medicine, Warsaw, Poland
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We conducted a prospective study of 312 patients (194 with multiple myeloma, 118 with lymphomas) receiving high-dose conditioning chemotherapy and autologous haematopoietic stem cell transplantation (auto-HSCT). Polymorphisms of MBL2 gene were investigated and serial measurements of serum concentration of mannose-binding lectin (MBL) were made. Serum samples were taken before conditioning chemotherapy, before HSCT and once weekly after (totally 4-5 samples); in minority of subjects also one and/or three months post transplantation. The results were compared with data from 267 healthy controls and analysed in relation to clinical data to explore possible associations with cancer and with chemotherapy-induced medical complications. We found a higher frequency of MBL deficiency-associated genotypes (LXA/O or O/O) among multiple myeloma patients compared with controls. It was however not associated with hospital infections or post-HSCT recovery of leukocytes, but seemed to be associated with the most severe infections during follow-up. The possible association of MBL2 gene 3âÂ?Â?-untranslated region polymorphism with cancer (lymphoma) in Caucasians was noted. Chemotherapy induced marked increase in serum MBL concentration, prolonged for several weeks. Our findings suggest that, in the context of chemotherapy of myeloma and lymphoma, MBL has little influence on infection during the short period of chemotherapy-induced neutropenia, but could have a protective effect when able to act in combination with phagocytic cells after their recovery. This work was supported by National Science Centre, Poland, grant UMO-2013/11/B/NZ6/01739.
Subjects
Immunology & MicrobiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Clinical and Cellular Immunology
- SubjectImmunology & Microbiology
- BylineArticles whose byline prints “Anna S. Swierzko”
- BylineArticles whose byline prints “Mateusz Michalski”
- BylineArticles whose byline prints “Anna Sokolowska”
- BylineArticles whose byline prints “Mateusz Nowicki”
- BylineArticles whose byline prints “Lukasz Eppa”
- BylineArticles whose byline prints “Agnieszka Szala-Pozdziej”
- BylineArticles whose byline prints “Iwona Mitrus”
- BylineArticles whose byline prints “Anna Szmigielska-Kaplon”
